India is a marketplace booming with smartphones duking it out on various price points. From the killer-budget phones to the ultra-flagships, there is a phone for everyone. Of course, the market ...
Here's looking at his six available options, from best to worst. Moore can go home again to his most notable former team. This would much like Jerry Jones tapping into the smarts of former backup ...
Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.